Naoko Ishikawa

2.7k total citations · 1 hit paper
48 papers, 1.5k citations indexed

About

Naoko Ishikawa is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Naoko Ishikawa has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 17 papers in Epidemiology and 11 papers in General Health Professions. Recurrent topics in Naoko Ishikawa's work include HIV/AIDS Research and Interventions (18 papers), HIV, Drug Use, Sexual Risk (10 papers) and Adolescent Sexual and Reproductive Health (10 papers). Naoko Ishikawa is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), HIV, Drug Use, Sexual Risk (10 papers) and Adolescent Sexual and Reproductive Health (10 papers). Naoko Ishikawa collaborates with scholars based in Japan, Philippines and Switzerland. Naoko Ishikawa's co-authors include Melanie Taylor, Masamine Jimba, Sumiyo Okawa, Lori M. Newman, Eline L. Korenromp, Maeve B. Mello, Nico Nagelkerke, Shinsuke Nakagawa, Mary L. Kamb and Kota Kodama and has published in prestigious journals such as PLoS ONE, PLoS Medicine and International Journal of Epidemiology.

In The Last Decade

Naoko Ishikawa

48 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of maternal and congenital syphilis and associated adverse birth outcomes—Estimates for 2016 and progress since 2012

2019 249 citations Eline L. Korenromp, Jane Rowley et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naoko Ishikawa Japan	22	592	538	332	319	248	48	1.5k
Nina Shah United States	24	576 1.0×	939 1.7×	140 0.4×	407 1.3×	687 2.8×	44	2.0k
Judith C. Shlay United States	21	503 0.8×	558 1.0×	165 0.5×	325 1.0×	171 0.7×	62	1.6k
Esther Robison United States	19	877 1.5×	421 0.8×	98 0.3×	312 1.0×	109 0.4×	32	1.6k
Lorie Benning United States	22	936 1.6×	579 1.1×	69 0.2×	164 0.5×	163 0.7×	44	1.9k
Alan R. Lifson United States	20	631 1.1×	430 0.8×	183 0.6×	398 1.2×	79 0.3×	42	1.2k
Han‐Zhu Qian United States	31	1.7k 2.9×	1.6k 3.0×	169 0.5×	454 1.4×	234 0.9×	134	2.7k
Sandra Wagner Cardoso Brazil	23	1.0k 1.7×	575 1.1×	89 0.3×	111 0.3×	101 0.4×	117	1.9k
Erik J.C. van Ameijden Netherlands	28	893 1.5×	1.6k 2.9×	60 0.2×	329 1.0×	645 2.6×	68	2.2k
Sara N. Glick United States	21	831 1.4×	1.1k 2.1×	45 0.1×	454 1.4×	385 1.6×	86	1.7k
R. Luke Shouse United States	20	1.1k 1.8×	888 1.7×	124 0.4×	404 1.3×	112 0.5×	58	1.4k

Countries citing papers authored by Naoko Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Naoko Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Ishikawa more than expected).

Fields of papers citing papers by Naoko Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Ishikawa. The network helps show where Naoko Ishikawa may publish in the future.

Co-authorship network of co-authors of Naoko Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Ishikawa. A scholar is included among the top collaborators of Naoko Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Ishikawa. Naoko Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schaefer, Robin, H Schmidt, Giovanni Ravasi, et al.. (2021). Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study. The Lancet HIV. 8(8). e502–e510. 64 indexed citations

Nishijima, Takeshi, Kei Kawana, Ichio Fukasawa, et al.. (2020). Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010–2018. Emerging infectious diseases. 26(6). 1192–1200. 22 indexed citations

Nguyen, Van Thi Thuy, et al.. (2020). Feasibility, benefits, and cost-effectiveness of adding universal hepatitis B and syphilis testing to routine antenatal care services in Thai Nguyen province, Vietnam. International Journal of STD & AIDS. 32(2). 135–143. 7 indexed citations

Vannakit, Ravipa, Stephen Mills, Michael Cassell, et al.. (2020). Fast-tracking the end of HIV in the Asia Pacific region: domestic funding of key population-led and civil society organisations. The Lancet HIV. 7(5). e366–e372. 22 indexed citations

Zhang, Lei, Yusha Tao, Joseph Woodring, et al.. (2019). Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation. International Journal of Epidemiology. 48(4). 1327–1339. 27 indexed citations

Harmancı, Hande, Yvan Hutin, Sarah Hess, et al.. (2019). Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017. JHEP Reports. 1(2). 81–89. 78 indexed citations

Korenromp, Eline L., Jane Rowley, Mónica Alonso, et al.. (2019). Global burden of maternal and congenital syphilis and associated adverse birth outcomes—Estimates for 2016 and progress since 2012. PLoS ONE. 14(2). e0211720–e0211720. 249 indexed citations breakdown →

Tsuzuki, Shinya, et al.. (2018). Disclosure to HIV-seropositive children in rural Zambia. BMC Pediatrics. 18(1). 272–272. 6 indexed citations

Korenromp, Eline L., et al.. (2018). Adult female syphilis prevalence, congenital syphilis case incidence and adverse birth outcomes, Mongolia 2000–2016: Estimates using the Spectrum STI tool. Infectious Disease Modelling. 3. 13–22. 10 indexed citations

10.

Taylor, Melanie, Lori M. Newman, Naoko Ishikawa, et al.. (2017). Elimination of mother-to-child transmission of HIV and Syphilis (EMTCT): Process, progress, and program integration. PLoS Medicine. 14(6). e1002329–e1002329. 59 indexed citations

11.

Okawa, Sumiyo, Mwiya Mwiya, Kimiyo Kikuchi, et al.. (2017). Adolescents’ Experiences and Their Suggestions for HIV Serostatus Disclosure in Zambia: A Mixed-Methods Study. Frontiers in Public Health. 5. 326–326. 20 indexed citations

12.

Ishikawa, Naoko, et al.. (2014). Health Outcomes and Cost Impact of the New WHO 2013 Guidelines on Prevention of Mother-to-Child Transmission of HIV in Zambia. PLoS ONE. 9(3). e90991–e90991. 30 indexed citations

13.

Miyano, Satoru, et al.. (2013). Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia. The International Journal of Tuberculosis and Lung Disease. 17(4). 540–545. 9 indexed citations

14.

Okada, Takashi, Satomi Murase, Branko Aleksić, et al.. (2012). Prospective Study on the Association between Harm Avoidance and Postpartum Depressive State in a Maternal Cohort of Japanese Women. PLoS ONE. 7(4). e34725–e34725. 12 indexed citations

15.

Okada, Takashi, Satomi Murase, Branko Aleksić, et al.. (2012). The Postpartum Depressive State in Relation to Perceived Rearing: A Prospective Cohort Study. PLoS ONE. 7(11). e50220–e50220. 15 indexed citations

16.

Nishioku, Tsuyoshi, Shinya Dohgu, Fuyuko Takata, et al.. (2008). Detachment of Brain Pericytes from the Basal Lamina is Involved in Disruption of the Blood–Brain Barrier Caused by Lipopolysaccharide-Induced Sepsis in Mice. Cellular and Molecular Neurobiology. 29(3). 309–316. 158 indexed citations

17.

Yoshiyama, Takashi & Naoko Ishikawa. (2000). [Epidemiology and control activities of tuberculosis in Japan].. PubMed. 58(5). 1167–74. 3 indexed citations

18.

Ishikawa, Naoko, et al.. (2000). Plasma levels of granulocyte elastase–α1‐proteinase inhibitor complex in children with hemolytic uremic syndrome caused by verotoxin‐producing Escherichia coli. Pediatrics International. 42(6). 637–641. 7 indexed citations

19.

Kamitsuji, Hidekazu, et al.. (1999). PLASMA P-SELECTIN IN CHILDREN WITH HEMOLYTIC UREMIC SYN-DROME CAUSED BY ESCHERICHIA COLI O157 : H7. 50(6). 515–523. 1 indexed citations

20.

Hasegawa, Shinya, Hideki Sawa, Kaoruko Shimizu, et al.. (1996). [Questionnaire survey of AIDS examination recipients at government-run public health center regarding AIDS awareness promotion and HIV examinations].. PubMed. 43(4). 276–85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact